Richard A. Urbanowicz
Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay
Urbanowicz, Richard A.; McClure, C. Patrick; King, Barnabas; Mason, Christopher P.; Ball, Jonathan K.; Tarr, Alexander W.
Authors
PATRICK MCCLURE PATRICK.MCCLURE@NOTTINGHAM.AC.UK
Assistant Professor
Barnabas King
Christopher P. Mason
Jonathan K. Ball
Dr ALEXANDER TARR alex.tarr@nottingham.ac.uk
Associate Professor
Abstract
Retrovirus pseudotypes are a highly tractable model used to study the entry pathways of enveloped viruses. This model has been extensively applied to the study of the hepatitis C virus (HCV) entry pathway, pre-clinical screening of antiviral antibodies and for assessing the phenotype of patient-derived viruses using HCV pseudoparticles (HCVpp) possessing the HCV E1 and E2 glycoproteins. However, not all patient-isolated clones produce particles that are infectious in this model. This study investigated factors that might limit phenotyping of patient-isolated HCV glycoproteins. Genetically related HCV glycoproteins from individual patient quasispecies were discovered to behave very differently in this entry model. Empirical optimisation of the ratio of packaging construct and glycoprotein-encoding plasmid was required for successful HCVpp genesis for different clones. The selection of retroviral packaging construct also influenced the function of HCV pseudoparticles. Some glycoprotein constructs tolerated a wide range of assay parameters, while others were much more sensitive to alterations. Furthermore, glycoproteins previously characterised as unable to mediate entry were found to be functional. These findings were validated using chimeric cell-cultured HCV bearing these glycoproteins. Using the same empirical approach we demonstrated that generation of infectious ebolavirus pseudoviruses (EBOVpv) were also sensitive to the amount, and ratio, of plasmids used, and that protocols for optimal production of these pseudoviruses is dependent on the exact virus glycoprotein construct. These findings demonstrate that it is crucial for studies utilising pseudoviruses to conduct empirical optimisation of pseudotype production for each specific glycoprotein sequence to achieve optimal titres and facilitate accurate phenotyping.
Citation
Urbanowicz, R. A., McClure, C. P., King, B., Mason, C. P., Ball, J. K., & Tarr, A. W. (2016). Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay. Journal of General Virology, 97(9), 2265-2279. https://doi.org/10.1099/jgv.0.000537
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 5, 2016 |
Online Publication Date | Sep 1, 2016 |
Publication Date | Sep 1, 2016 |
Deposit Date | Jul 29, 2016 |
Publicly Available Date | Sep 1, 2016 |
Journal | Journal of General Virology |
Print ISSN | 0022-1317 |
Electronic ISSN | 1465-2099 |
Publisher | Microbiology Society |
Peer Reviewed | Peer Reviewed |
Volume | 97 |
Issue | 9 |
Pages | 2265-2279 |
DOI | https://doi.org/10.1099/jgv.0.000537 |
Public URL | https://nottingham-repository.worktribe.com/output/803407 |
Publisher URL | http://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.000537 |
Contract Date | Jul 29, 2016 |
Files
2265_jgv000537.pdf
(3.7 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search